Cancer Institute A national cancer institute
designated cancer center

John Ioannidis

Publication Details

  • Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.

    Boletis JN, Ioannidis JP, Boki KA, Moutsopoulos HM. Lancet. 1999; 354 (9178): 569-70

    Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard intravenous cyclophosphamide treatment. Pulsed immunoglobulin may be a useful alternative therapy in lupus nephritis.

    PubMedID: 10470708

Stanford Medicine Resources:

Footer Links: